Daily Stock Ratings & Price Targets

Daily stock ratings from over 8,000 Wall Street analysts

Daily Buy Ratings

Analyst & Firm	Company	Rating & Price Target	Upside / Downside
Matthew Clark Piper Sandler	FFWM First Foundation	BUY$6.75	24.08% Upside
Tom Forte Maxim Group	AMZN Amazon	BUY$280	14.65% Upside
Aaron Rakers Wells Fargo	WDC Western Digital	BUY$180	19.83% Upside
Jeffrey Wlodarczak Pivotal Research	ROKU Roku	BUY$135	27.20% Upside

Daily Sell Ratings

Analyst & Firm	Company	Rating & Price Target	Upside / Downside
Sophie Karp KeyBanc	FSLR First Solar	SELL$150	-43.81% Downside
Jonathan Chappell Evercore ISI	WERN Werner Enterprises	SELL$20	-23.66% Downside
Patrick Wood Morgan Stanley	IART Integra Lifesciences	SELL$10	-16.74% Downside
Toni Kaplan Morgan Stanley	BFAM Bright Horizons	SELL$99	-9.37% Downside

Full List of Stock Ratings

(Nov 3, 2025)

Analyst Performance

Any

Analyst Rating

Any

Upside / Downside

Any

Action

Any

Market Cap

Any

Analyst & Firm	Company	Rating & Price Target	Upside / Downside	Average Return	Action	Date	Article
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $6→$6.75	―	8.60%	Upgraded	2025-11-02
Matt Larew William Blair	ATR AptarGroup	HOLD	―	-0.90%	Downgraded	2025-11-01	AptarGroup's Resilience and Strategic Focus Drive Buy Rating Despite Mixed Results
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD	―	9.60%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD	―	13.60%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $88	―	19.50%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $180	―	18.20%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $110	―	6.20%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $210→$300	―	19.80%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $52→$62	―	12.00%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $25	―	8.40%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD	―	15.70%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD	―	40.80%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD	―	3.50%	Reiterated	2025-10-31
Siti Panigrahi Mizuho Securities	KVYO Klaviyo, Inc. Class A	BUY $45	―	-0.20%	Reiterated	2025-10-31	Klaviyo, Inc. Class A (KVYO) Receives a Buy from Mizuho Securities
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $570	―	6.80%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $525	―	22.50%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $300→$320	―	7.00%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $387	―	6.90%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $370→$353	―	6.90%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $190	―	22.50%	Reiterated	2025-10-31
Robert Ottenstein Evercore ISI	EL The Estée Lauder Companies	BUY $115	―	0.00%	Reiterated	2025-10-31	The Estée Lauder Companies (EL) Receives a Buy from Evercore ISI
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $86	―	4.10%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $80	―	6.70%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $75	―	10.40%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $59	―	4.10%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $37→$49	―	28.50%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $46	―	6.80%	Reiterated	2025-10-31
Steve Sakwa Evercore ISI	CDP COPT Defense Properties	BUY $35	―	0.10%	Reiterated	2025-10-31	COPT Defense Properties (CDP) Receives a Buy from Evercore ISI
Steve Sakwa Evercore ISI	CUZ Cousins Properties	HOLD $32	―	0.10%	Reiterated	2025-10-31	Evercore ISI Sticks to Their Hold Rating for Cousins Properties (CUZ)
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $12	―	11.50%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $4	―	4.10%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $260→$300	―	11.30%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $273→$285	―	6.70%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $285→$270	―	5.10%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $220→$235	―	6.70%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $205→$220	―	15.40%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $320→$350	―	6.70%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $360→$350	―	9.30%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $135→$155	―	26.70%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $110→$130	―	11.30%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $21→$19	―	9.30%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $3.5	―	9.10%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $140	―	0.80%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $154	―	0.80%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $7.5→$11	―	12.00%	Downgraded	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $120→$240	―	24.90%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $199→$175	―	10.50%	Reiterated	2025-10-31
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $155→$162	―	9.30%	Reiterated	2025-10-31
Itay Michaeli TD Cowen	APTV Aptiv	BUY $104→$107	―	-19.70%	Reiterated	2025-10-31	Analysts Offer Insights on Consumer Cyclical Companies: Clarus (NASDAQ: CLAR) and Aptiv (NYSE: APTV)
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $52→$55	―	10.50%	Reiterated	2025-10-31

Rows:

Ready for the Full Picture?Your current plan limits your access to top-tier analyst ratings. Subscribe to Premium now and unlock the full range of ratings from the highest-ranked analysts on Wall Street. Don't let partial views limit your market research potential - upgrade today!

Upgrade Now Plans & Pricing